Kathryn Boyd
Family · Conway, ARNPI 1265514368
Payments from drug & device makers
Across 144 payments — averaging $15.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$491
- Biogen$237
- Bayer$231
- Mayne Pharma Commercial LLC$136
- Pfizer$123
- Sumitomo Pharma America, Inc.$106
- plus $900 from 20 others
What the payments were for
- Food & beverage$2,225100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 39 | $491 |
| Biogen | 11 | $237 |
| Bayer | 15 | $231 |
| Mayne Pharma Commercial LLC | 12 | $136 |
| Pfizer | 8 | $123 |
| Sumitomo Pharma America, Inc. | 5 | $106 |
| Organon | 7 | $98 |
| Bristol Myers Squibb | 3 | $79 |
| Evofem Biosciences, Inc. | 5 | $71 |
| Myovant Sciences Inc. | 5 | $70 |
| Shield Therapeutics Inc | 3 | $67 |
| Astellas Pharma US Inc | 4 | $66 |
| Millicent US Inc | 4 | $62 |
| Merck | 3 | $47 |
| Avion Pharmaceuticals | 3 | $45 |
| Urovant Sciences Inc | 3 | $45 |
| Hologic Sales And Service, LLC | 2 | $43 |
| Smith+Nephew | 2 | $37 |
| Amgen | 2 | $36 |
| Innovation Technologies Inc | 1 | $32 |
| Medtronic | 2 | $31 |
| Baudax Bio Inc. | 1 | $17 |
| GSK | 1 | $15 |
| Mylan Pharmaceuticals Inc. | 1 | $15 |
| Aspira Women's Health Inc | 1 | $14 |
| Therapeuticsmd, Inc. | 1 | $11 |
How this compares
$2,225 in reported general payments places this provider in the 80th percentile of 2,103 family providers in Arkansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ImvexxyEstradiol | 13 | $2,628 |
| Estradiol | 86 | $1,697 |
| Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet | 21 | $1,026 |
| ProgesteroneProgesterone, Micronized | 26 | $361 |
| Medroxyprogesterone Acetate | 17 | $322 |
| Tarina Fe 1-20 EqNorethindrone-E.Estradiol-Iron | 13 | $254 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 13 | $144 |
| Fluconazole | 14 | $121 |
| Norethindrone Acetate | 11 | $109 |
| Alendronate Sodium | 13 | $33 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Therapeuticsmd, Inc.Imvexxy | $11 | $2,62813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,103 family providers in Arkansas.
Other family in Conway
- Meghan MallettConway$25K
- Sheila ForresterConway$17K
- Elana RussellConway$17K
- Donald KulbethConway$12K
- Kayla JohnsonConway$9K
- Crystal BrownConway$9K
- Leah CarringtonRogers$1.6M
- Nina CopelandFort Smith$207K
- Stefanie BrackinJonesboro$51K
- Amanda DavisFort Smith$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.